Enjoy a Better Life - Tips and Tools 


Astellas enters into contract with Medivation to develop MDV3100 Astellas Pharma Inc.

The companies will share equally all U.S. Advancement costs, commercialization costs, and profits. Astellas shall have responsibility for developing and commercializing MDV3100 beyond your U.S. And will pay Medivation tiered double-digit royalties on ex-U.S. Product sales. We are very happy to initiate a great partnership with Medivation, mentioned Masafumi Nogimori, president and chief executive officer of Astellas. We believe that MDV3100 gets the unique potential to determine a new treatment approach for prostate cancers. Astellas already gets the global knowledge in urology and the solid commitment to spotlight oncology. Continue reading

EPSRC highlights just how researchers are harnessing the gas intended for beneficial make use of.

Now for the very first time, thanks to chemistry, an answer appears to have been found. The brand new CO-releasing molecules have already been developed together with Dr Roberto Motterlini at Northwick Park Institute for Medical Study and with financing from the Engineering and Physical Sciences Research Council . They can be made to launch CO over a period of between thirty minutes and many hours, based on what is required to treat a particular medical condition. In addition to boosting survival cutting and prices recovery times, the brand new molecules could ease pressure on medical center budgets by reducing enough time that patients need to spend in medical center, for example after an operation. Continue reading